Szakonyi, Zs.; Gonda, T.; Otvos, S. B.; Fulop, F.; Tetrahedron: Asymmetry, 2014, 25, 1138-1145
Synthesis, biological evaluation, and molecular modeling of new 3‑(cyclopentyloxy)-4-methoxybenzaldehyde O‑(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) related phosphodiesterase 4D (PDE4D) inhibitors
Brullo, C.; Massa, M.; Rocca, M; Rotolo, C.; Guariento, S.; Rivera, D.; Ricciarelli, R.; Fedele, E.; Fossa, P.; Bruno, O.; J. Med. Chem., 2014, 57(16), 7061-7072
Synthesis of cross‐linked glycopeptides and ureas by a mechanochemical, solvent‐free reaction and determination of their structural properties by TEM and X‐ray crystallography
Kumar, V.; Giri, S. K.; Venugopalan, P.; Kartha, K. P. R.; ChemPlusChem, 2014, 79(11), 1605-1613
Benzoxazinone synthesis via Passerini–Smiles couplings
Martinand-Lurin, E.; El Kaim, L.; Grimaud, L.; Tetrahedron Letters, 2014, 55(37), 5144-5146
Synthesis of aromatic 13C/2H-α-ketoacid precursors to be used in selective phenylalanine and tyrosine protein labelling
Lichtenecker, R. J.; Org. Biomol. Chem., 2014, 12, 7551-7560
N-[6-(4-butanoyl-5-methyl-1H-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1H-indole-3-carboxamide (SAR216471), a novel intravenous and oral, reversible, and directly acting P2Y12 antagonist
Boldron, C.; Besse, A.; Bordes, M.; Tissandie, S.; Yvon, X.; Gau, B.; Badorc, A.; Rousseaux, T.; Barre, G.; Meneyrol, J.; Zech, G.; Nazare, M.; Fossey, V.; Pflieger, A.; Bonnet-Lignon, S.; Millet, L.; Briot, C.; Dol, F.; Herault, J.; Savi, P.; Lassalle, G.; Delesque, N.; Herbert, J.; Bono, F.; J. Med. Chem., 2014, 57(17), 7293-7316
Cubanes in medicinal chemistry: Synthesis of functionalized building blocks
Wlochal, J.; Davies, R. D. M.; Burton, J.; Org. Lett., 2014, 16, 4094-4097
Beyond the use of modifiers in selective alkyne hydrogenation: silver and gold nanocatalysts in flow mode for sustainable alkene production
Vile, G.; Perez-Ramirez, J.; Nanoscale, 2014, 6, 13476-13482
Synthesis of riboflavines, quinoxalinones and benzodiazepines through chemoselective flow based hydrogenations
Baumann, M.; Baxendale, I. R.; Hornung, C. H.; Ley, S. V.; Rojo, M. V; Roper, K. A.; Molecules, 2014, 19(7), 9736-9759
Towards the development of chromone-based MEK1/2 modulators
Redwan, I. N.; Dyrager, C.; Solano, C.; de Troconiz, G. F.; Voisin, L.; Bliman, D.; Meloche, S.; Grotli, M.; Eur. J. Med. Chem., 2014, 85, 127-138

